Jun 05, 2019 / 09:00PM GMT
Tsan-Yu Hsieh - William Blair & Company L.L.C., Research Division - Senior Research Analyst
Okay. I think we'll get started. I'd like to welcome you all to our 39th Annual Growth Stock Conference, and we're very pleased to have the management team of Exelixis to present and tell a story for us.
Given the name Growth Stock Conference, if you were to pick a growth stock in the biotech sector, this is a prime example, highlighted by their 150% top line growth in 2017, followed by another 75%-plus growth top line in 2018. We've been covering the story for a long time. We first initiated 12 years ago on the name. So we do have a very long track record of following the company. So without further ado, I'll pass it on to the CFO of the company, Chris Senner.
Christopher J. Senner - Exelixis, Inc. - Executive VP & CFO
Thanks, Andy. So, a slightly different format today. We're going to do about 15 minutes of -- 10, 15 minutes of slides. We'll take you through kind of a general overview of the company, and then Andy -- we're going to go
Exelixis Inc at William Blair Growth Stock Conference Transcript
Jun 06, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers